144 related articles for article (PubMed ID: 14556085)
1. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart.
Frascarelli S; Ghelardoni S; Ronca-Testoni S; Zucchi R
Basic Res Cardiol; 2003 Nov; 98(6):401-5. PubMed ID: 14556085
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
Muccioli G; Pons N; Ghè C; Catapano F; Granata R; Ghigo E
Eur J Pharmacol; 2004 Sep; 498(1-3):27-35. PubMed ID: 15363972
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats.
Li L; Zhang LK; Pang YZ; Pan CS; Qi YF; Chen L; Wang X; Tang CS; Zhang J
Acta Pharmacol Sin; 2006 May; 27(5):527-35. PubMed ID: 16626506
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin plays a minor role in the physiological control of cardiac function in the rat.
Torsello A; Bresciani E; Rossoni G; Avallone R; Tulipano G; Cocchi D; Bulgarelli I; Deghenghi R; Berti F; Locatelli V
Endocrinology; 2003 May; 144(5):1787-92. PubMed ID: 12697684
[TBL] [Abstract][Full Text] [Related]
5. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.
Cassoni P; Papotti M; Ghè C; Catapano F; Sapino A; Graziani A; Deghenghi R; Reissmann T; Ghigo E; Muccioli G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1738-45. PubMed ID: 11297611
[TBL] [Abstract][Full Text] [Related]
6. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
Ghè C; Cassoni P; Catapano F; Marrocco T; Deghenghi R; Ghigo E; Muccioli G; Papotti M
Endocrinology; 2002 Feb; 143(2):484-91. PubMed ID: 11796502
[TBL] [Abstract][Full Text] [Related]
7. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide.
Konturek PC; Brzozowski T; Walter B; Burnat G; Hess T; Hahn EG; Konturek SJ
Eur J Pharmacol; 2006 Apr; 536(1-2):171-81. PubMed ID: 16581065
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin: endocrine and non-endocrine actions.
Broglio F; Arvat E; Benso A; Papotti M; Muccioli G; Deghenghi R; Ghigo E
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1219-27. PubMed ID: 12510973
[TBL] [Abstract][Full Text] [Related]
11. Role of growth hormone and insulin-like growth factor-1 in the protective effect of ghrelin in ischemia/reperfusion-induced acute pancreatitis.
Dembiński A; Warzecha Z; Ceranowicz P; Cieszkowski J; Pawlik WW; Tomaszewska R; Kuśnierz-Cabala B; Naskalski JW; Kuwahara A; Kato I
Growth Horm IGF Res; 2006; 16(5-6):348-56. PubMed ID: 17084100
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific effects of parathyroid hormone-related peptide: modification by aging and hypertension.
Ross G; Schlüter KD
Cardiovasc Res; 2005 May; 66(2):334-44. PubMed ID: 15820202
[TBL] [Abstract][Full Text] [Related]
13. Contractile effects of Ghrelin and expression of its receptor GHS-R1a in normal and hypertrophic myocardium.
Soares JB; Rocha-Sousa A; Castro-Chaves P; Henriques-Coelho T; Lourenço AP; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2005 Oct; 24(10):1235-42. PubMed ID: 16398240
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone secretagogue binding sites in peripheral human tissues.
Papotti M; Ghè C; Cassoni P; Catapano F; Deghenghi R; Ghigo E; Muccioli G
J Clin Endocrinol Metab; 2000 Oct; 85(10):3803-7. PubMed ID: 11061542
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term effects of melatonin on myocardial post-ischemic recovery.
Lochner A; Genade S; Davids A; Ytrehus K; Moolman JA
J Pineal Res; 2006 Jan; 40(1):56-63. PubMed ID: 16313499
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin-induced growth hormone release from isolated rat anterior pituitary cells depends on intracellullar and extracellular Ca2+ sources.
Yamazaki M; Kobayashi H; Tanaka T; Kangawa K; Inoue K; Sakai T
J Neuroendocrinol; 2004 Oct; 16(10):825-31. PubMed ID: 15500542
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences.
Benso A; Broglio F; Marafetti L; Lucatello B; Seardo MA; Granata R; Martina V; Papotti M; Muccioli G; Ghigo E
Semin Vasc Med; 2004 May; 4(2):107-14. PubMed ID: 15478030
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium.
Ma Y; Zhang L; Edwards JN; Launikonis BS; Chen C
PLoS One; 2012; 7(4):e35265. PubMed ID: 22493744
[TBL] [Abstract][Full Text] [Related]
19. Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium.
Rossoni G; Locatelli V; Gennaro Colonna Vd ; Müller EE; Berti F
Pharmacol Res; 2000 Aug; 42(2):129-36. PubMed ID: 10887041
[TBL] [Abstract][Full Text] [Related]
20. The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
Huang J; Li Y; Zhang J; Liu Y; Lu Q
Int Heart J; 2017 Apr; 58(2):257-263. PubMed ID: 28321024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
